Drug: Orenitram (treprostinil)

Manufacturer: United Therapeutics

Route of Administration: Oral

Site of Care: Outpatient

Approved Indication: treatment of pulmonary arterial hypertension (PAH, WHO group 1) to delay disease progression and to improve exercise capacity

Disease: pulmonary arterial hypertension

Therapeutic Area: Pulmonary

Enrollment Form Link: orenitramhcp.com/starting-patients

Phone Number: 844-864-8437

Fax Number: 1-800-380-5294

Product Website: orenitram.com